Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SIB-1508Y neuronal acetylcholine ion channel agonist regulating release of dopamine and acetylcholine data

SIBI announced that Phase I testing in 48 healthy volunteers revealed no abnormal changes

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE